June 8, 2021
Seattle’s city council has taken a step towards decriminalizing psychedelics as Councilmembers signed a letter on Monday, suggesting that a local overdose task force include entheogens for treating “substance addiction and behavioural mental health conditions”. Seven out of nine Councilmembers signed the letter sent to the Overdose Emergency and Innovative Recovery (OEIR) Task Force, asking to “add to their work plan an examination of [the] public policy governing psychedelic medicines.” Two members are yet to vote.
Full articleJune 6, 2021
Psilocybin, the active compound in magic mushrooms, may be at least as effective as selective serotonin reuptake inhibitors, the leading type of antidepressant medication, according to research published in the New England Journal of Medicine. The phase 2, double-blind, randomized, controlled trial compared psilocybin to the antidepressant medication escitalopram.
Full articleJune 1, 2021
A bill to legalize possession of psychedelics in California was approved by the California Senate on Tuesday. The legislation, sponsored by Sen. Scott Wiener (D), which previously cleared three committees, passed 21-16 on the floor.
Full articleMay 9, 2021
Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences.
Full articleApril 16, 2021
In November 2020, Oregon became the first state in the union and one of the few places in the world to legalize psilocybin (psychedelic mushrooms) for therapeutic purposes. Sales will not begin for two years while the Oregon Health Authority creates a regulatory framework for the substance. The market for psychedelic mushrooms will not look like legal cannabis. The substance is still a Schedule I drug and will only be administered under supervision. But the drug will not be relegated to those with prescriptions.
Full article